Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4IDT8
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 320 | 324 | PF00656 | 0.564 |
CLV_C14_Caspase3-7 | 350 | 354 | PF00656 | 0.441 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.310 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 185 | 187 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.631 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.559 |
CLV_NRD_NRD_1 | 356 | 358 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 360 | 362 | PF00675 | 0.242 |
CLV_NRD_NRD_1 | 406 | 408 | PF00675 | 0.314 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.441 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.270 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.631 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 559 | 561 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.440 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.578 |
CLV_PCSK_PC1ET2_1 | 559 | 561 | PF00082 | 0.656 |
CLV_PCSK_PC7_1 | 555 | 561 | PF00082 | 0.642 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.579 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.527 |
CLV_PCSK_SKI1_1 | 268 | 272 | PF00082 | 0.578 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 548 | 552 | PF00082 | 0.602 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.281 |
CLV_Separin_Metazoa | 58 | 62 | PF03568 | 0.388 |
DEG_SPOP_SBC_1 | 13 | 17 | PF00917 | 0.739 |
DOC_CKS1_1 | 192 | 197 | PF01111 | 0.308 |
DOC_CYCLIN_RxL_1 | 65 | 74 | PF00134 | 0.489 |
DOC_MAPK_gen_1 | 357 | 365 | PF00069 | 0.494 |
DOC_MAPK_MEF2A_6 | 358 | 367 | PF00069 | 0.519 |
DOC_MAPK_MEF2A_6 | 529 | 538 | PF00069 | 0.412 |
DOC_PP1_RVXF_1 | 130 | 137 | PF00149 | 0.465 |
DOC_PP1_RVXF_1 | 388 | 395 | PF00149 | 0.465 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.722 |
DOC_USP7_MATH_1 | 331 | 335 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 366 | 370 | PF00917 | 0.465 |
DOC_USP7_MATH_1 | 527 | 531 | PF00917 | 0.346 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.514 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.302 |
DOC_WW_Pin1_4 | 83 | 88 | PF00397 | 0.593 |
LIG_14-3-3_CanoR_1 | 185 | 189 | PF00244 | 0.349 |
LIG_14-3-3_CanoR_1 | 208 | 216 | PF00244 | 0.322 |
LIG_14-3-3_CanoR_1 | 407 | 413 | PF00244 | 0.514 |
LIG_14-3-3_CanoR_1 | 459 | 464 | PF00244 | 0.528 |
LIG_14-3-3_CanoR_1 | 467 | 475 | PF00244 | 0.496 |
LIG_14-3-3_CanoR_1 | 512 | 521 | PF00244 | 0.319 |
LIG_Actin_WH2_2 | 192 | 210 | PF00022 | 0.383 |
LIG_Actin_WH2_2 | 533 | 550 | PF00022 | 0.401 |
LIG_APCC_ABBA_1 | 193 | 198 | PF00400 | 0.391 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.659 |
LIG_BIR_III_4 | 304 | 308 | PF00653 | 0.530 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.623 |
LIG_Clathr_ClatBox_1 | 199 | 203 | PF01394 | 0.348 |
LIG_Clathr_ClatBox_1 | 241 | 245 | PF01394 | 0.328 |
LIG_deltaCOP1_diTrp_1 | 508 | 519 | PF00928 | 0.408 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.381 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.657 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.453 |
LIG_FHA_1 | 448 | 454 | PF00498 | 0.467 |
LIG_FHA_1 | 458 | 464 | PF00498 | 0.488 |
LIG_FHA_1 | 513 | 519 | PF00498 | 0.326 |
LIG_FHA_1 | 542 | 548 | PF00498 | 0.421 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.594 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.531 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.465 |
LIG_FHA_2 | 100 | 106 | PF00498 | 0.530 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.390 |
LIG_FHA_2 | 339 | 345 | PF00498 | 0.340 |
LIG_FHA_2 | 348 | 354 | PF00498 | 0.426 |
LIG_GBD_Chelix_1 | 103 | 111 | PF00786 | 0.366 |
LIG_LIR_Apic_2 | 2 | 7 | PF02991 | 0.634 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 239 | 248 | PF02991 | 0.395 |
LIG_LIR_Gen_1 | 279 | 290 | PF02991 | 0.375 |
LIG_LIR_Gen_1 | 362 | 371 | PF02991 | 0.454 |
LIG_LIR_Gen_1 | 391 | 398 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 123 | 127 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 194 | 199 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 239 | 243 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 279 | 285 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.509 |
LIG_LIR_Nem_3 | 391 | 397 | PF02991 | 0.465 |
LIG_LRP6_Inhibitor_1 | 60 | 66 | PF00058 | 0.183 |
LIG_MYND_1 | 83 | 87 | PF01753 | 0.588 |
LIG_PCNA_PIPBox_1 | 481 | 490 | PF02747 | 0.426 |
LIG_PCNA_yPIPBox_3 | 481 | 490 | PF02747 | 0.343 |
LIG_Pex14_1 | 115 | 119 | PF04695 | 0.521 |
LIG_Pex14_2 | 173 | 177 | PF04695 | 0.299 |
LIG_Pex14_2 | 424 | 428 | PF04695 | 0.446 |
LIG_SH2_CRK | 149 | 153 | PF00017 | 0.317 |
LIG_SH2_NCK_1 | 410 | 414 | PF00017 | 0.540 |
LIG_SH2_NCK_1 | 436 | 440 | PF00017 | 0.454 |
LIG_SH2_PTP2 | 4 | 7 | PF00017 | 0.621 |
LIG_SH2_SRC | 4 | 7 | PF00017 | 0.621 |
LIG_SH2_STAP1 | 269 | 273 | PF00017 | 0.435 |
LIG_SH2_STAP1 | 410 | 414 | PF00017 | 0.540 |
LIG_SH2_STAP1 | 449 | 453 | PF00017 | 0.461 |
LIG_SH2_STAP1 | 454 | 458 | PF00017 | 0.478 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.598 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.237 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 364 | 367 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 449 | 452 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 487 | 490 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 535 | 538 | PF00017 | 0.394 |
LIG_SUMO_SIM_anti_2 | 102 | 108 | PF11976 | 0.525 |
LIG_SUMO_SIM_anti_2 | 144 | 149 | PF11976 | 0.359 |
LIG_SUMO_SIM_anti_2 | 295 | 300 | PF11976 | 0.421 |
LIG_SUMO_SIM_anti_2 | 470 | 476 | PF11976 | 0.445 |
LIG_SUMO_SIM_anti_2 | 55 | 62 | PF11976 | 0.388 |
LIG_SUMO_SIM_par_1 | 141 | 146 | PF11976 | 0.367 |
LIG_TRAF2_1 | 277 | 280 | PF00917 | 0.380 |
LIG_TRAF2_1 | 550 | 553 | PF00917 | 0.425 |
LIG_TYR_ITIM | 147 | 152 | PF00017 | 0.361 |
LIG_UBA3_1 | 147 | 154 | PF00899 | 0.409 |
LIG_UBA3_1 | 243 | 251 | PF00899 | 0.476 |
LIG_UBA3_1 | 484 | 490 | PF00899 | 0.426 |
MOD_CDK_SPxK_1 | 191 | 197 | PF00069 | 0.387 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.482 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.529 |
MOD_CK1_1 | 338 | 344 | PF00069 | 0.373 |
MOD_CK1_1 | 440 | 446 | PF00069 | 0.453 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.468 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.495 |
MOD_CK2_1 | 338 | 344 | PF00069 | 0.393 |
MOD_CK2_1 | 435 | 441 | PF00069 | 0.350 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.394 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.419 |
MOD_GlcNHglycan | 325 | 328 | PF01048 | 0.736 |
MOD_GlcNHglycan | 341 | 344 | PF01048 | 0.254 |
MOD_GlcNHglycan | 437 | 440 | PF01048 | 0.455 |
MOD_GlcNHglycan | 498 | 501 | PF01048 | 0.529 |
MOD_GlcNHglycan | 529 | 532 | PF01048 | 0.462 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.412 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.648 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.442 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.718 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.399 |
MOD_GSK3_1 | 459 | 466 | PF00069 | 0.474 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.475 |
MOD_LATS_1 | 433 | 439 | PF00433 | 0.426 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.445 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.360 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.546 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.461 |
MOD_NEK2_1 | 345 | 350 | PF00069 | 0.464 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.316 |
MOD_NEK2_1 | 367 | 372 | PF00069 | 0.322 |
MOD_NEK2_1 | 417 | 422 | PF00069 | 0.306 |
MOD_NEK2_1 | 457 | 462 | PF00069 | 0.363 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.377 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.362 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.515 |
MOD_PIKK_1 | 477 | 483 | PF00454 | 0.317 |
MOD_PIKK_1 | 512 | 518 | PF00454 | 0.518 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.467 |
MOD_PK_1 | 459 | 465 | PF00069 | 0.374 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.371 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.407 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.427 |
MOD_PKA_2 | 367 | 373 | PF00069 | 0.302 |
MOD_Plk_1 | 128 | 134 | PF00069 | 0.396 |
MOD_Plk_1 | 262 | 268 | PF00069 | 0.401 |
MOD_Plk_1 | 388 | 394 | PF00069 | 0.317 |
MOD_Plk_1 | 440 | 446 | PF00069 | 0.386 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.480 |
MOD_Plk_2-3 | 184 | 190 | PF00069 | 0.525 |
MOD_Plk_2-3 | 99 | 105 | PF00069 | 0.419 |
MOD_Plk_4 | 347 | 353 | PF00069 | 0.393 |
MOD_Plk_4 | 459 | 465 | PF00069 | 0.417 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.424 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.380 |
MOD_ProDKin_1 | 83 | 89 | PF00069 | 0.497 |
MOD_SUMO_rev_2 | 253 | 261 | PF00179 | 0.564 |
MOD_SUMO_rev_2 | 353 | 359 | PF00179 | 0.428 |
TRG_DiLeu_BaEn_1 | 479 | 484 | PF01217 | 0.426 |
TRG_DiLeu_LyEn_5 | 479 | 484 | PF01217 | 0.336 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 240 | 243 | PF00928 | 0.507 |
TRG_ENDOCYTIC_2 | 282 | 285 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 406 | 409 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 454 | 457 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 535 | 538 | PF00928 | 0.468 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.378 |
TRG_ER_diArg_1 | 359 | 361 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 560 | 563 | PF00400 | 0.539 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.349 |
TRG_NES_CRM1_1 | 190 | 206 | PF08389 | 0.521 |
TRG_NES_CRM1_1 | 235 | 247 | PF08389 | 0.527 |
TRG_NES_CRM1_1 | 526 | 542 | PF08389 | 0.504 |
TRG_NLS_MonoExtC_3 | 558 | 564 | PF00514 | 0.590 |
TRG_Pf-PMV_PEXEL_1 | 109 | 114 | PF00026 | 0.404 |
TRG_Pf-PMV_PEXEL_1 | 357 | 362 | PF00026 | 0.348 |
TRG_Pf-PMV_PEXEL_1 | 482 | 486 | PF00026 | 0.336 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCA4 | Leptomonas seymouri | 79% | 99% |
A0A0S4JKH9 | Bodo saltans | 37% | 100% |
A0A1X0P4F9 | Trypanosomatidae | 51% | 93% |
A0A3S5IRG5 | Trypanosoma rangeli | 56% | 95% |
A0A3S7XBU7 | Leishmania donovani | 99% | 100% |
A4HQ32 | Leishmania braziliensis | 87% | 100% |
D0A8T4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 97% |
E9ATV0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
P0CM96 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 30% | 68% |
P0CM97 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 30% | 68% |
Q4Q0P6 | Leishmania major | 96% | 100% |
Q52KN9 | Xenopus laevis | 29% | 70% |
Q59XY0 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 22% | 87% |
Q6BU84 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 25% | 89% |
Q751P4 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 22% | 100% |
V5DNB7 | Trypanosoma cruzi | 54% | 89% |